Chemoinformaics analysis of (+)-14-taraxeren-3beta-ol
Molecular Weight | 426.729 | nRot | 0 |
Heavy Atom Molecular Weight | 376.329 | nRig | 26 |
Exact Molecular Weight | 426.386 | nRing | 5 |
Solubility: LogS | -6.365 | nHRing | 0 |
Solubility: LogP | 6.744 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 84.2417 |
nHD | 1 | BPOL | 50.1604 |
QED | 0.387 |
Synth | 4.8 |
Natural Product Likeliness | 2.976 |
NR-PPAR-gamma | 0.072 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.02 |
Pgp-sub | 0 |
HIA | 0.008 |
CACO-2 | -5.079 |
MDCK | 0.00000747 |
BBB | 0.257 |
PPB | 0.9807 |
VDSS | 1.389 |
FU | 0.0236 |
CYP1A2-inh | 0.027 |
CYP1A2-sub | 0.422 |
CYP2c19-inh | 0.075 |
CYP2c19-sub | 0.956 |
CYP2c9-inh | 0.112 |
CYP2c9-sub | 0.643 |
CYP2d6-inh | 0.067 |
CYP2d6-sub | 0.629 |
CYP3a4-inh | 0.326 |
CYP3a4-sub | 0.297 |
CL | 6.235 |
T12 | 0.07 |
hERG | 0.028 |
Ames | 0.001 |
ROA | 0.128 |
SkinSen | 0.907 |
Carcinogencity | 0.012 |
EI | 0.637 |
Respiratory | 0.896 |
NR-Aromatase | 0.495 |
Antiviral | No |
Prediction | 0.788692 |